pharmaphorum highlights this week’s biggest pharma news from the COVID-19 epidemic, as life science companies scramble to find treatments and vaccines for the coronavirus.
Digital healthcare firm LIVI has launched a free and secure web-based platform to add capacity to pressurised health systems and help clinicians interact with patients self-isolating at hom
Gilead has rescinded its request for orphan status for its potential COVID-19 antiviral remdesivir amid a furore over its pricing should it get to market.
A consortium of life sciences companies including pharma giants such as Novartis and Johnson & Johnson, are to collaborate to develop and manufacture vaccines, diagnostics and treatment
